Another study on the Moroccan population found a high expression of p53 in tumor tissue in 93% (39) of patients with an incomplete response and in only 7% of complete responders, demonstrating that p53 may be of prognostic value in the therapeutic response of LARC [75]. This evidence concerns the gene TP53 and neoplasm.